Our goal is to be one of the world’s most innovative, best performing and trusted healthcare companies.

Our values and expectations are at the heart of everything we do and help define our culture - so that together we can deliver extraordinary things for our patients and consumers and make GSK a brilliant place to work. Our values are Patient focus, Transparency, Respect, Integrity. Our expectations are Courage, Accountability, Development, Teamwork.

We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our three global businesses, scientific and technical know-how and talented people.

Our Pharmaceuticals business has a broad portfolio of innovative and established medicines with leadership positions in respiratory and HIV. Our R&D approach focuses on science related to the immune system, use of genetics and advanced technologies.

Our Vaccines business has a broad portfolio and innovative pipeline of vaccines to help protect people throughout life. We deliver over two million vaccine doses per day to people living in over 160 countries.

Complementary information

The number of persons reflects the full time employment falling under the scope of the register. GSK follows the guidelines provided by EFPIA regarding this registration.

Person in charge of EU relations

Person with legal responsibility

Category

II - In-house lobbyists and trade/professional associations

Subcategory

Companies & groups

Affiliation

Association of the European Self-Medication Industry (AESGP)
European Brands Association (AIM)
American Chamber of Commerce to the European Union (AmChamEU)
British Chamber of Commerce to EU & Belgium (BritCham)
Cosmetics Europe
European Federation of Pharmaceutical Industries and Associations (EFPIA)
Vaccines Europe (VE)
EPC
Friends of Europe
Ambrosetti
Hanbury Strategy
Acumen

Member organisations

N/A

Lobbying costs

1,750,000€ - 1,999,999€

Procurement from EU institutions

0 €

Grants from EU institutions

461,295 €

Total budget

0 €

Total public financing

0 €

Other financial information

For the declaration of funding received from EU institutions, GSK is following the Transparency Register Implementing Guidelines from October 2015, with the declared amount corresponding to the information provided by the European Financial Transparency System. Currently, this information is referring to the closed financial year of 2018, being updated to 2019 when the update of the European Financial Transparency System is made. €

There are no notes attached to this organisation.

High-level groups

Consultative committees

Expert groups (European Commission)

none

Intergroups (European Parliament)

None

Industry forums (European Parliament)

None

Complementary information

Meetings with European Commission

10 meetings found.

The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't publish information about such meetings. All information below comes from European Commission web pages.